(Q39493057)

12 September 2017

High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy (English)

1 reference

Adaptive radiation therapy

12 September 2017

0 references

esophageal squamous cell carcinoma

1 reference

inferred from title

squamous cell carcinoma

1 reference

Hongxia Zhu

1

1 reference

12 September 2017

Qifeng Wang

2

1 reference

12 September 2017

Chenfei Hu

3

1 reference

12 September 2017

Wencheng Zhang

4

1 reference

12 September 2017

Lanping Quan

5

1 reference

12 September 2017

Mei Liu

6

1 reference

12 September 2017

Ningzhi Xu

7

1 reference

12 September 2017

Zefen Xiao

8

1 reference

12 September 2017

9 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

32

1 reference

12 September 2017

6

1 reference

12 September 2017

1147-1153

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-011-0217-y

12 September 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Significance of nuclear accumulation of Foxo3a in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Tumor-specific gene expression using the survivin promoter is further increased by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Survivin, versatile modulation of cell division and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Survivin and escaping in therapy-induced cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Radiation-induced survivin nuclear accumulation is linked to DNA damage repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0217-Y

Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

21 January 2018

1 reference

12 December 2020

High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy

1 reference

12 December 2020

Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.

1 reference

12 December 2020

A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma

1 reference

12 December 2020

[Expression of survivin and its significance in esophageal cancer]

1 reference

12 December 2020

Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression.

1 reference

12 December 2020

Nuclear survivin expression predicts poorer prognosis in glioblastoma

1 reference

12 December 2020

Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma

1 reference

12 December 2020

[Anti-apoptosis gene survivin promotes cell growth and transformation].

1 reference

12 December 2020

10.1007/S13277-011-0217-Y

Identifiers

DOI

1 reference

12 September 2017

1 reference